Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/2440Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Majumder, Syamantak | - |
| dc.date.accessioned | 2021-10-02T17:50:05Z | - |
| dc.date.available | 2021-10-02T17:50:05Z | - |
| dc.date.issued | 2009-11-30 | - |
| dc.identifier.uri | https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2009.00446.x | - |
| dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/2440 | - |
| dc.description.abstract | Nitric oxide (NO) promotes angiogenesis by activating endothelial cells. Thalidomide arrests angiogenesis by interacting with the NO pathway, but its putative targets are not known. Here, we have attempted to identify these targets | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Wiley | en_US |
| dc.subject | Biology | en_US |
| dc.subject | Thalidomide | en_US |
| dc.subject | Nitric oxide-driven | en_US |
| dc.subject | Guanylyl cyclase | en_US |
| dc.title | Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Department of Biological Sciences | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.